ABSTRACT -Despite massive research efforts, the exact pathogenesis and pathophysiology of psychiatric disorders, such as schizophrenia and bipolar disorder, remain largely unknown. Animal models can strains were found to exhibit behavioral abnormalities reminiscent of human psychiatric disorders. Here -foundly dysregulated behaviorbehaviours and impaired neuronal development in the dentate gyrus (DG).
INTRODUCTION
Elucidating the neural and genetic factors underlying psychiatric illness is hampered by the current methods of clinical diagnosis (Bearden et al -tion and investigation of clinical endophenotypes might be one solution (Gottesman and Gould, 2003) , but represents a considerable challenge in human subjects. Therefore, establishing animal models of psychiatric disorders is essential for understanding the pathogenesis/pathophysiology of the disorders (Gainetdinov et al., 2001; Powell and Miyakawa, 2006; Chen et al., 2006; Arguello and Gogos, 2006) . Gene targeting was successfully et al et al., on a specific behavior can be determined by conducting behavioral analysis of mutant mice lacking that gene.
-entists to investigate the relationships between genes, the brain, and behaviors in a direct and unprecedented way.
distinct behavioral domains, from simple sensorimotor functions to highly cognitive functions like learning and memory (Fig. 1) . Once a particular strain of mutant -have been conducting a behavioral test battery covering many domains to screen the behavioral significance of -erate a hypothesis, and then test it through collaboration -ioral phenotype (Takao et al using this strategy for more than 10 years, it has worked remarkably well (Miyakawa et al 2001b and 2001c; Yamada et al., 2001; Zeng et al., 2001; Gerber et al., 2003; Miyakawa et al., 2003; Arron et al., et al et al et 
Animal model of psychiatric disorder
An animal model can be generated by introducing the same mutation that is known to cause a particular disease caused by a single mutation (Powell and Miyakawa, 2006) is difficult because psychiatric disorders are caused by multiple genes and environmental factors in many cases, and the etiology is often not fully known. Therefore, - F: prepulse inhibition / startle response, G: latent inhibition / fear conditioning ble symptom or pathogenic feature of the disease for an -mal models of diseases, it is necessary to have criteria by -ing the validity of animal models, three factors should be considered (Takao et al -ly, 1) construct validity, 2) Predictive validity and 3) face of a disease with an animal model, the animal model of the disease is considered to meet the criteria for construct validity. To establish construct validity, the pathophysiological characteristics of the animal model should of psychiatric disorders introducing the gene mutations or environmental factors that are assumed to be related to the disease enable us to investigate the pathophysiology of the disease and the interaction between the gene and the environment.
Predictive validity is important when using animal models to investigate new treatments. Predictability of the clinical effect of a medication in human disease is typimedicine is effective in an animal model of a particular disease, the predictive validity is considered to be high. However, for example, some patients with schizophrenia show improvement with haloperidol treatment, while other patients do not. This is not surprising since these neuropsychiatric disorders consist of multiple subpopulations with diverse biological etiologies, which in turn can result in diversity in the effect of a medication. Thus, even when a well characterized medication has no effect in an animal model, it cannot be concluded that the model does Face validity of an animal model is evaluated by how well the model mimics the symptoms of human diseases. However, psychiatric disorders are often heterogeneous and a patient does not necessarily have all known symptoms of the disease. The diagnostic criteria for schizocharacteristic symptoms described are: (1) delusions, (2) hallucinations, (3) disorganized speech, (4) grossly dis--toms. A diagnosis of schizophrenia is made if a patient has 2 or more of these symptoms, without consideration of the underlying biological factors. Therefore, an animal model of schizophrenia or other psychiatric disorders does not necessarily have to reproduce all of the behavioral abnormalities corresponding to the symptoms of the disease in humans in order to have face validity. Thus, -der to completely satisfy the criteria for these 3 validity (Takao et al., 2007) .
Discovery-oriented approach using behavioral test battery -al to introduce to mice a genetic mutation that is known to cause a neuropsychiatric disorder in humans, and then to look into what is happening in the brains of mice harboring the mutation (Table 2) . However, for disorders in which causative genetic mutations rarely occur or are hard Psychiatric disorders such as schizophrenia, bipolar disorcases, another approach, in which we start from studies in mice and then proceed to human studies, can be effective.
prospectively look for a genetic association between polymorphism of the gene and/or the genes in signaling pathways or neural mechanisms related to the given gene that cause the behavioral abnormalities in mice and the symptoms/endophenotypes of the disease in humans (Gould and Gottesman, 2006 ). An example of discovery-oriented approach are the study started form behavioral characmight underlie the pathogenesis of schizophrenia.
Schizophrenia research started from behavioral phenotyping of CN knockout mice /calmodulin-dependent serin/threonine pro---were created using the cre-loxP system to test the role of calcineurin in learning and memory. These mutant mice, -in working/episodic-like memory but completely normal reference memory (Zeng et al., 2001) . Because casu--hensive behavioral test battery to examine these abnormalities in greater detail (Crawley, 2000) . The test battery -motor activity, decreased social interaction, and impairimpaired nesting behavior. Collectively, the abnormalidescribed for schizophrenia. Based on these results, we conducted a literature search and found that there is considerable indirect evidence supporting the hypothesis that abnormality of calcineurin-related processes may be related to schizophrenia. For example, there are 2 major hypotheses regarding the pathogenesis of schizophrenia --the hyperdoperminergic hypothesis and the hypoglutamatergic hypothesis --and these hypotheses seemed conof the N doperminergic pathway (Greengard et al details of other indirect supportive evidence, see Takao and Miyakawa (Takao and Miyakawa, 2006) . -of schizophrenic patients (Gerber et al., 2003) . Thus, the underlie the pathogenesis of schizophrenia. Recent study and schizophrenia by using Japanese schizophrenic pedigrees (Yamada et al., 2007) . They conducted genetic analysis of the calcineurin pathway and found 3 genes in EGR -nia (Yamada et al -cant associations between polymorphism in PPP3CC and the subgroup of schizophrenia with deficits of the sustained attention and the executive functioning as tested by Test (Liu et al., 2007) . Those suggest that PPP3CC gene are involved in cognitive dysfunction of schizopnrenia.
A phenotypic screen of genetically engineered mutant mice
Based on those findings on the relationship between - ciently obtain a mouse model of psychiatric disorders by applying a comprehensive behavioral test battery (Crawley, 2000) to various strains of mice bearing mutations of the genes encoding the molecules involved in (Takao and Miyakawa, 2006) . Among them, the mutant --ophrenia and other psychiatric disorders (Goldman-Rakic, -dant in the brain (up to 2% of the total protein); a holoenzyme that consists of four isozymes (alpha, beta, gamma and delta); phosphorylates protein substrates, such L-type Ca channels, and MAP-2, and itself by autophosphorylation; and is important for long-term potentiet al et al ---cit and an exaggerated infradian rhythm (cycle of increases and decreases in locomotor activity in their home cage; 2-3 weeks/cycle) (Fig. 2) , which are comparable to the symptoms observed in patients diagnosed with schizophrenia and other psychiatric disorders (Yamasaki et al -ecule of N-methyl-D-aspartate type glutamate receptors, which have attracted the attention of schizophrenia researchers in relation to the hypo-glutamatergic hypothesis of the disorder. To obtain more information about the mechanisms underlying behavioral abnormality in alpha--ysis of the hippocampus of these mutants and detected 2,000 genes. Among the 30 most downregulated genes, 6 had highly selective expression in the dentate gyrus (DG) (Yamasaki et al two regions where new neurons are continuously generated, even in adulthood. Adult neurogenesis, as assessed by BrdU staining, was greater in these mutant mice compared to normal mice (Yamasaki et al An increase in adult neurogenesis induced by physical exercise or by selective serotonin reuptake inhibitors, a class of anti-depressant drugs, is considered to posi---munications with other neurons and glial cells to develop into their mature state and to integrate into the brain --phologic, and electrophysiologic features. By conducting a series of experiments, we discovered that almost all the neurons in the mutant DG were very similar to the immature DG neurons of normal rodents. (Kesner, 2007a (Kesner, , 2007b . Lesion studies demonstrated that damage of dentate gyrus caused working memory deficit in radial maze (Xavier et al., et al., 2001) . Dentate gyrus is activated by spatial working memory task as assessed by 2-deoxyglucose study using monkeys (Friedman and -ping in rodents using immediately early genes, such as c-Fos (Vann et al., 2000) and Arc (Kubik et al., 2007) . Others reported that there was a highly positive correlation between spatial working memory performance and et al., et al synapses exhibit long-term plasticity phenomena, such as may contribute to hippocampal memory processing. DG is a candidate for an endophenotype of schizophrenia. Researches with the approach using animal model with endophenotype of schizophrenia. Dysbindin-1 has been one of the most studied and promising schizophrenia sus- of dysbindin-1 was relatively restricted in dentate gyrus (Talbot et al., 2004) . This presynaptic reduction of dysbindin-1 protein was inversely correlated with increase in vesicular glutamate transporter-1, indicating the glutamatergic alterations in intrinsic hippocampal formation con--ity in dentate gyrus in hippocampus and spatial working as a gene that is truncated and cosegregates with major neuropsychiatric disorders including schizophrenia in a et al., 2000) . Mice lacking -spatial working memory (Li et al that our approach starting from comprehensive behavioral test battery on genetically engineered mice provides consistent results with the approaches started from susceptia behavioral test battery, which would be more likely to be used when comprehensive and systematic behavioral phenotyping has been on a larger scale in a greater number of strains of mutant mice. There are many advantages to using such mouse models to study behavioral abnormalities related to psychiatric disorders. Unlike in human psychiatric disorders, the etiologies of the behavioral abnormalities in genetically engineered mice are well known and genetic backgrounds can be perfectly controlled. Moreover, we can study what happens in the brain of such mice using the most advanced, cutting-edge technologies including invasive ones such as in vivo tetmice, Foster et al -ry measured neuronal activities in CA1 hippocampus during behaving and rest/sleep periods to investigate chang--out, but not in the control, during rest/sleep (Foster et al., 2006) . Ripple events seem to be associated with replay of past events (Axmacher et al., 2006) and this phenotype is of special interest with respect to the symptom of psychiatric disorders. This kind of approach with invasive methods, such as in vivo tetrode recording systems, is almost impossible with human patients. Once endophenotypes in the brain of model mice are determined, human disease can be approached with completely new hypotheses (Gould and Gottesman, 2006) . This is what we refer to as a discovery-oriented approach.
Potential impact of large-scale mice phenotyping projects
Although the genome project has now been finished
do not yet know the functions of most of these genes.
humans, three major mouse knockout programs KnockOut Mouse Project (KOMP), http://www.knockoutmouse. org, EUCOMM: EUropean Conditional Mouse Mutagenhttp://norcomm.phenogenomics.ca/index.htm) are underway worldwide, working together to mutate all proteinencoding genes in the mouse using a combination of gene -out Consortium, 2007) . The strategy used in these programs is actually similar to the one we have been using behavioral phenotype (Fig. 3, unpublished data) . This surprising fact may indicate that many of the genes expressed in the brain could have functions that affect behavior.
After creating a substantial number of mouse modpsychiatric disorders can be prepared. Any given human psychiatric disorder may consist of many different biologically distinct etiological entities. Each mutant mouse strain may represent only a subpopulation of such psyis developed, it would be reasonable to test its effect on many different strains of mutant mice in several different behavioral assays, since such an agent may only be effective in treating some symptoms in particular strains of mutant mice. Once we are able to identify the corresubpopulations of human patients, agents developed by out method may be effective as so-called tailor-made therapies. above would accelerate our understanding of how genetic alterations result in behavioral abnormalities, further our knowledge of the pathogenesis and pathophysiology of psychiatric disorders, and lead to better pharmacotheracan be used to elucidate the effect of substances. A chemical can be assumed to affect neural mechanisms that play a role in regulating a specific behavior if that behavior is altered in mice with the administration of the chemi--ior phenotypes of mutant mice by using comprehensive effects of the chemical on behavior, we can search for genetically engineered mice that exhibit similar behavio--tial number of mouse strains that show abnormal behavbehavioral abnormalities at least partially with mice treat-- ior phenotyping of the mutant mice with the behavioral abnormalities to speculate which molecule and/or signaling pathway and which region of the brain could be involved in the behavioral abnormality. Thus, we can speculate how the chemical works in the brain.
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